143 related articles for article (PubMed ID: 12009112)
1. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
[TBL] [Abstract][Full Text] [Related]
2. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
3. Preparation of F(ab')
Ismael BN; Abass KS; Khalil KA; Salih KA
Biologicals; 2018 Nov; 56():19-23. PubMed ID: 30153952
[TBL] [Abstract][Full Text] [Related]
4. Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.
Hammoudi-Triki D; Lefort J; Rougeot C; Robbe-Vincent A; Bon C; Laraba-Djebari F; Choumet V
Toxicol Appl Pharmacol; 2007 Feb; 218(3):205-14. PubMed ID: 17198719
[TBL] [Abstract][Full Text] [Related]
5. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments.
Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD
Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578
[TBL] [Abstract][Full Text] [Related]
6. Purification of F(ab')2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield.
dos Santos MC; D'Império Lima MR; Furtado GC; Colletto GM; Kipnis TL; Dias da Silva W
Toxicon; 1989; 27(3):297-303. PubMed ID: 2728022
[TBL] [Abstract][Full Text] [Related]
7. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
Padilla A; Govezensky T; Possani LD; Larralde C
Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719
[TBL] [Abstract][Full Text] [Related]
8. Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius hoffmann.
Selisko B; Cosío G; García C; Becerril B; Possani LD; Horjales E
Toxicon; 2004 Jan; 43(1):43-51. PubMed ID: 15037028
[TBL] [Abstract][Full Text] [Related]
9. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics.
Vázquez H; Olvera F; Alagón A; Sevcik C
Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma.
Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
Ismail M; Abd-Elsalam MA
Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a F(ab')2 scorpion antivenom in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Mancilla-Nava R; Paniagua-Solís J; Alagón A; Sevcik C
Toxicon; 2005 Dec; 46(7):797-805. PubMed ID: 16197974
[TBL] [Abstract][Full Text] [Related]
14. A study on the use of caprylic acid and ammonium sulfate in combination for the fractionation of equine antivenom F(ab')(2).
Simsiriwong P; Eursakun S; Ratanabanangkoon K
Biologicals; 2012 Sep; 40(5):338-44. PubMed ID: 22704919
[TBL] [Abstract][Full Text] [Related]
15. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
[TBL] [Abstract][Full Text] [Related]
16. Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab')2 antivenoms and other drugs.
Sevcik C; Salazar V; Díaz P; D'Suze G
Toxicon; 2007 Oct; 50(5):653-65. PubMed ID: 17689580
[TBL] [Abstract][Full Text] [Related]
17. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays.
Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D
Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221
[TBL] [Abstract][Full Text] [Related]
18. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
19. New method to produce equine antirabies immunoglobulin F(ab')₂ fragments from crude plasma in high quality and yield.
Kittipongwarakarn S; Hawe A; Tantipolphan R; Limsuwun K; Khomvilai S; Puttipipatkhachorn S; Jiskoot W
Eur J Pharm Biopharm; 2011 Jun; 78(2):189-95. PubMed ID: 21414404
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom.
Segura A; León G; Su CY; Gutiérrez JM; Burnouf T
Biologicals; 2009 Oct; 37(5):306-12. PubMed ID: 19540775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
